AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $216,216 | -12.6% | 8,736 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $247,404 | -89.1% | 8,736 | -91.1% | 0.00% | -87.5% |
Q1 2023 | $2,264,452 | +71582.6% | 98,583 | -12.4% | 0.01% | -27.3% |
Q4 2022 | $3,159 | -99.9% | 112,488 | +20.1% | 0.01% | +10.0% |
Q3 2022 | $2,648,000 | +9.3% | 93,649 | -14.3% | 0.01% | +11.1% |
Q2 2022 | $2,423,000 | -11.9% | 109,302 | +112.6% | 0.01% | -50.0% |
Q2 2020 | $2,750,000 | – | 51,412 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |